Interestingly, patients with gastric cancer with high FOXM1/low RNF112 displayed the shortest survival, indicating that the combination of the 2 indices could predict the survival of patients more sensitively (Figure 8, F–H). This evidence concerns the gene FOXM1 and gastric cancer.